Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases - 27/10/20
pages | 22 |
Iconographies | 10 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Pharmacological basis and mechanism of tanshinone for multifaceted diseases
Highlights |
• | Tanshinone widely displays potent effect on various metabolic, acute or chronic diseases. |
• | Tanshinone demonstrates the multiple therapeutic effect via network of complex mechanisms. |
• | Tanshinone might be promising agents for various cancers and multiple system diseases. |
Abstract |
Drug development has long included the systematic exploration of various resources. Among these, natural products are one of the most important resources from which novel agents are developed due to the multiple pharmacologic effects of these natural products on diseases. Tanshinone, a representative natural product, is the main compound extracted from the dried root and rhizome of Salvia miltiorrhiza Bge. Research on tanshinone began in the early 1930s. With the in-depth investigation of an increasing number of identified analogs, tanshinone has demonstrated a wide variety of bioactivities and contradicted the saying, ‘You can’t teach an old dog new tricks’. This review is focused on the pharmacological action of tanshinone and status of research on tanshinone in recent years. The mechanism of tanshinone has also drawn much attention, with the findings of representative targets and pathways of tanshinone. The most recent studies have comprehensively shown that tanshinone can be used to treat leukemia and solid carcinoma, protect against cardiovascular and cerebrovascular diseases, and alleviate liver- and kidney-related diseases, among its other effects. Multiple signaling pathways, including antiproliferative, antiapoptotic, anti-inflammatory, and antioxidative stress pathways, are involved in its actions.
Le texte complet de cet article est disponible en PDF.Keywords : Tanshinone, Multifaceted disease, Pharmacological action, Mechanism
Plan
Vol 130
Article 110599- octobre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?